Recruiting NA INTERVENTIONAL 2-arm NCT07149064

Effect of Chronic Exposure to Nextida GC-B on Glycemic Control in Adults With Normoglycemia or Prediabetes

A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Efficacy and Safety of Chronic Exposure to Nextida GC-B on Glycemic Control in Adults With Normoglycemia or Prediabetes

Sponsor: KGK Science Inc.

Conditions Glycemic Control Normoglycemia Prediabetes

Interventions Nextida GC-B Placebo

Updated 3 times since 2025 Last updated: Mar 3, 2026 Started: Mar 31, 2026 Primary completion: Aug 31, 2026 Completion: Aug 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glycemic Control and Normoglycemia, this trial is actively recruiting participants. The trial is conducted by KGK Science Inc. and has accumulated 3 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Mar 2026 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2026 — Mar 2026 [monthly]

Not Yet Recruiting NA
Sep 2025 — Feb 2026 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KGK Science Inc.
Rousselot BVBA

Data source: Rousselot BVBA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada